Management ChangeOct 13, 2026, 04:06 PM
Niki BioSolutions Appoints Thomas Freeburg as CFO; $250K Salary + Options
AI Summary
Niki BioSolutions, Inc. announced the appointment of Thomas Freeburg as its new Chief Financial Officer, effective September 1, 2026. Mr. Freeburg's compensation package includes a base salary of $250,000, an annual bonus of up to 50% of his base salary, and 50,000 stock options. His salary is subject to an increase upon the company securing additional funding, and a portion of his initial salary will be deferred until such funding is received. The appointment is for a two-year term unless terminated earlier.
Key Highlights
- Thomas Freeburg appointed Chief Financial Officer of Niki BioSolutions, Inc.
- Mr. Freeburg's base salary is $250,000, potentially increasing to $275,000.
- He is eligible for an annual bonus of up to 50% of his base salary.
- Mr. Freeburg will receive 50,000 stock options with an exercise price of $8.83 per share.
- Employment agreement includes a deferred compensation component tied to company funding.
Price Impact
More from APM